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Disruption of Teashirt Zinc Finger Homeobox 1
Is Associated with Congenital Aural Atresia in Humans
Ilse Feenstra,1,* Lisenka E.L.M. Vissers,1,2 Ronald J.E. Pennings,3,4 Willy Nillessen,1 Rolph Pfundt,1
Henricus P. Kunst,3,4 Ronald J. Admiraal,3,4 Joris A. Veltman,1,2 Conny M.A. van Ravenswaaij-Arts,5
Han G. Brunner,1,2,6 and Cor W.R.J. Cremers3,4,6
Congenital aural atresia (CAA) can occur as an isolated congenital malformation or in the context of a number of monogenic and chro-
mosomal syndromes. CAA is frequently seen in individuals with an 18q deletion, which is characterized by intellectual disability,
reduced white-matter myelination, foot deformities, and distinctive facial features. Previous work has indicated that a critical region
for CAA is located in 18q22.3.We studied four individuals (from two families) with CAA and other features suggestive of an 18q deletion,
and we detected overlapping microdeletions in 18q22.3 in both families. The minimal region of deletion overlap (72.9–73.4 Mb) con-
tained only one known gene, TSHZ1, which was recently shown to be important for murinemiddle-ear development. Sequence analysis
of the coding exons in TSHZ1 in a cohort of 11 individuals with isolated, nonsyndromic bilateral CAA revealed two mutations,
c.723G>A (p.Trp241X) and c.946_947delinsA (p.Pro316ThrfsX16), and both mutations predicted a loss of function. Together, these
results demonstrate that hemizygosity of TSHZ1 leads to congenital aural atresia as a result of haploinsufficiency.Congenital aural atresia (CAA) is a rare malformation of
the ear that occurs in approximately 1 in 10,000 live
births.1 It presents unilaterally more often than bilaterally.
Its characteristics can vary from a narrow external auditory
canal and hypoplasia of the tympanic membrane and
middle ear cleft to a complete absence of middle-ear struc-
tures and anotia (bony atresia of the external auditory
canal and hypoplasia of inner ear structures). In the past,
different classifications of CAA have been introduced on
the basis of clinical findings. In 1955, Altmannwas the first
to describe a CAA classification,1 which has been modified
over the years by others.2–4 CAA type I is classified by
a bony or fibrous atresia of the lateral part of the external
auditory canal and an almost normal medial part and
middle ear. CAA type II is the most frequent type and is
characterized by partial or total aplasia of the external audi-
tory canal. In type IIA, the external auditory canal is either
affected by a complete bony atresia of its medial part or
partially aplastic, ending blindly in a fistula that leads to
a rudimentary tympanic membrane. CAA type IIB is char-
acterized by a bony stenosis of the total length of the
external auditory canal. Finally, CAA type III is character-
ized by bony atresia of the external auditory canal and
a very small or absent middle-ear cavity.2
CAAmight be present as an isolated malformation but is
also seen as a feature of complex syndromes such as
Crouzon syndrome [MIM 123500], Treacher Collins
syndrome [MIM 154500], Townes Brocks syndrome [MIM
107480], and branchiootorenal syndrome [MIM 113650],
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The Americandrome (45,X) and trisomies 13, 18, and 21.5–10 Although
not fully penetrant, CAA type IIA in the absence of micro-
tia or anotia is most frequently seen in individuals with
a deletion of the long arm of chromosome 18 (MIM
601808).11 In 1964, De Grouchy described individuals
with an 18q deletion, stating that they displayed CAA
and a wide range of associated features including short
stature, characteristic facial features, intellectual disability,
and foot deformities.11,12
The majority of individuals with an 18q deletion carry
a microscopically visible terminal deletion of the long
arm of chromosome 18.13 Yet, in a small subset of individ-
uals, routine cytogenetic studies reveal a normal G banded
karyotype.
Several genotype-phenotype studies have been per-
formed in persons with 18q deletions of various sizes
so that critical regions corresponding to the different
clinical symptoms of the 18q deletion syndrome could
be defined.14–16 These efforts have resulted in overlapping
critical regions for white-matter disorders and delayed
myelination, growth hormone insufficiency, foot defor-
mities, and CAA, all nested within the region from
18q22.3 to 18q23.14,16 Given that multiple genes reside
in the region of deletion overlap, it was concluded that
further studies would be needed to determine whether
the typical 18q deletion syndrome represents a single
gene disorder or whether it should be considered a contig-
uous deletion syndrome.14 Fine mapping of microscopi-
cally visible deletions via molecular techniques, such as
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Table 1. Overview of Clinical Features in Eight Individuals with an 18q22.3q23 Microdeletion or TSHZ1 Mutation
Individual Deletion/Mutation Age (yr)
Intellectual
Disability
Hearing
Lossa (L/R) Type of CAA Other
1 (family 1) 4.3 Mb deletion 8 mild 17 dB/22 dB narrow external
auditory canals
epilepsy, autism
2 (family 2) 2.5 Mb deletion 30 borderline 60 dB/60 dB IIA, bilateral bilateral vertical talus,
strabismus
3 (family 2) 2.5 Mb deletion 5 normal 65 dB/65 dB IIA, bilateral bilateral vertical talus
4 (family 2) 2.5 Mb deletion 1 mild motor delay 70 dB/45 dB IIA, bilateral bilateral vertical talus
5 (family 3) c.723G>A 10 normal 42 dB/42 dB IIA, bilateral no
6 (family 4) c.946_947delinsA 41 normal 40 dB/40 dB IIA, bilateral no
7 (family 4) c.946_947delinsA 12 normal 50 dB/55 dB IIA, bilateral no
8 (family 4) c.946_947delinsA 12 normal 48 dB/45 dB IIA, bilateral no
Mb, megabase; L, left; R, right; CAA, congenital aural atresia; Type IIA, complete bony atresia of the medial part of the external auditory canal, or the canal is
partially aplastic and ends blindly in a fistula that leads to a rudimentary tympanic membrane.
a Measurement of air conduction before surgical intervention or use of bone-anchored hearing aid.region in 18q22.3q23 (between markers D18S489 and
D18S554). However, it remained unclear whether CAA
could be separated from the other common features of
the 18q deletion syndrome.17,18
Here, we report that isolated CAA and the CAA pheno-
type in the 18q deletion syndrome are both caused by
haploinsufficiency that results from a heterozygous dele-
tion or loss-of-function mutation of TSHZ1, whose ortho-
log is essential for murine middle-ear development.19
All procedures were performed in accordance with the
ethical standards of the Radboud University Nijmegen
Medical Centre Ethical Committee. After obtaining in-
formed consent, we evaluated the presence of microdele-
tions in four individuals (from two different families) who
had a phenotype consistent with the 18q deletion
syndrome. We used 250K (Nsp1) single-nucleotide poly-
morphism (SNP)microarrays (Affymetrix, Inc., SantaClara,
CA, USA).20 SNP microarray experiments were performed
according to the manufacturer’s instructions. Copy-
number estimates were determined with the CNAG soft-
ware package v2.0, and the genomic locations of the SNP
positionsweremapped according to theGenomeReference
Consortium Human Genome Build 37 (GRCh37).
Individual 1 is the second son from nonconsanguineous
parents. He was born at term after an uncomplicated preg-
nancy and had a normal birth weight. Psychomotor devel-
opment was delayed: He started walking at 21months, and
at the age of 4 years, a 10–15 month delay in speech and
language development was detected. A pure-tone audio-
gram was performed when the child was cooperative at
4 years of age and showed mild left- and right-sided
conductive low-frequency hearing loss of 17 and 22 dB,
respectively (Table 1). At eight years of age, he developed
epileptic seizures, and EEG abnormalities occurred after
sleep deprivation. He was also noted to have mild intellec-
tual disability (an IQ of 60) and behavioral problems
involving autistic features. He was a cooperative, healthy814 The American Journal of Human Genetics 89, 813–819, Decembboy with a normal height and head circumference. His
dysmorphic features included hypertelorism, an upturned
nasal tip, and a thin upper lip (Figure 1A). CT scans showed
bilateral, narrow external auditory canals. This finding was
confirmed by otoscopy, from which only a small part of
the tympanic membrane could be visualized (Figure 3A).
SNP-array analysis of DNA isolated from blood revealed
a 4.3 Mb interstitial deletion in 18q22.3q23, extending
between the genomic coordinates 69.2 and 73.4 Mb (arr
snp 18q22.3q23 [SNP_A-2065000 > SNP_A-184607]31;
Figure 2A). SNP-array analysis of the phenotypically
normal mother revealed no abnormalities. The father was
not available for testing.
Individual 2 is a 30-year-old woman, born at 39 weeks
gestation after an uneventful pregnancy to unrelated,
healthy parents. Directly after birth, bilateral forefoot
deformities were noted and classified as congenital vertical
talus (Figure 1B), for which she received surgical treatment.
She could walk from the age of 2 years. At the age of
15 months, she presented with a bilateral conductive
60 dB hearing loss, which was caused by bilateral atresia
of the external auditory canals, consistent with CAA type
IIA (Table 1). She received hearing aids and consequently
developed speech, although a delay remained. At ten years
of age, the aural atresia of her right ear was successfully
operated on, and at the age of 26, she received a bone-
anchored hearing aid (BAHA) on the left side. Physical
examination at the age of 30 years showed a healthy
woman with normal height, weight, and head circumfer-
ence. Dysmorphic features included hypertelorism, midfa-
cial hypoplasia, and a broad mouth with prominent lips.
There was a normal implantation of the ears, which
showed a prominent superior crus of the antihelix and
underdevelopment of the descending part of the helix
(Figure 1B).
SNP-array analysis revealed a 2.5 Mb interstitial deletion
between the genomic coordinates 72.9 and 75.4 Mb (arrer 9, 2011
Figure 1. Pedigrees and Clinical Pictures of Affected Individuals
The individuals with an 18q22.3q23 microdeletion are depicted above (families 1 and 2), and the pedigrees of individuals with a TSHZ1
mutation are depicted below (families 3 and 4).
Note the mild dysmorphic features in individual 1 (A), including hypertelorism, an upturned nasal tip, and a thin upper lip. The mother
(B) and sons (C and D) of family 2 display several features in common, consisting of hypertelorism, down-slanting palpebral fissures,
a broad mouth, characteristic low-set ears, and bilateral foot deformities.snp 18q22.3q23 [SNP_A-1893660 > SNP_A-1815424]31;
Figure 2A).
Individual 3 is the first son of individual 2 and her
healthy husband. He was born after an uneventful preg-
nancy at term and had normal birth parameters. Like his
mother, he had congenital bilateral vertical talus and bilat-
eral CAA type IIA (Table 1). Computed tomography (CT)
scans showed significant narrowing of the external audi-
tory canals, opacification of the mastoid and middle ear
probably related to otitis media, and normal anatomical
aspects of the inner ear.
During the first years of life, his hearing was assisted by
a bone-conductive hearing aid on a softband. The latter
was replaced by a percutaneous titanium screw at the age
of 4 3/4 years. Examination at 5 1/2 years of age showed
a healthy, cooperative boy with normal height, weight,
and head circumference. Dysmorphisms included hyperte-
lorism, mild down-slanting palpebral fissures, a broad
mouth, and characteristic low-set ears with a prominentThe Americansuperior crus of the antihelix and hypoplasia of the de-
scending helix (Figure 1C). SNP-array analysis revealed
the same 2.5 Mb interstitial deletion (arr snp 18q22.3q23
[SNP_A-1893660 > SNP_A-1815424]31) as observed in
his affected mother (data not shown).
Individual 4 is the second child of individual 2. A
prenatal ultrasound at 20 weeks gestation showed congen-
ital bilateral vertical talus. He was born at term after an
otherwise uncomplicated pregnancy and had a normal
birth weight. Similar to his mother and older brother, he
had congenital bilateral vertical talus and distinctive dys-
morphic features including hypertelorism and low-set
ears with hypoplasia of the descending helix (Figure 1D).
Otoscopic examination showed bilateral narrowing of
the auditory canals, consistent with CAA type IIA.
During the last examination at the age of 1 year, his
parents reported amotor delay. SNP-array analysis revealed
the same 2.5 Mb interstitial deletion (arr snp 18q22.3q23
[SNP_A-1893660 > SNP_A-1815424]31) as observed inJournal of Human Genetics 89, 813–819, December 9, 2011 815
Figure 2. Detailed Genomic View of 18q23.3q23; Organization of TSHZ1 and Mutations Detected
(A) A schematic representation shows the transcriptsmapped to the 18q23.3q23 region. Deletions detected by SNP-array analysis in indi-
vidual 1 and family 2 are shown by red solid lines, and details on the first and last deleted SNPs are annotated in gray. The shortest region
of deletion overlap contains a known gene, TSHZ1, and an open reading frame, c18orf62, of unknown function.
(B) A schematic representation of the TSHZ1 protein shows its domain structure. Targeted Sanger sequencing of TSHZ1 in families 3 and
4 revealed mutations in both families; the mutations are shown as partial electropherograms for both families, respectively. Of note, the
protein sequence denoted below the electropherograms only shows the mutated sequence.his affected mother and brother (data not shown), indi-
cating full cosegregation of the deletion with the pheno-
type in this family.
Interestingly, the microdeletions in individuals 1 and 2
(and both her sons) showed a 459 kb deletion overlap,
which contains one hypothetical protein (C180rf62) and
a single known gene, Teashirt Zinc Finger Homeobox 1
(TSHZ1; NM_005786.4) (Figure 2). TSHZ1 was considered
to be a good candidate gene for the observed CAA pheno-
type on the basis of the deletion overlap and the fact that
all four individuals presented with the common feature of
narrow or atretic external auditory canals. This hypothesis
was further supported by previously reported Tshz1 loss-of-
function mutations in mice; these mutations lead to
specific malformations of the middle ear components19
and emphasized the importance of TSHZ1 in the devel-
oping middle ear. Therefore, conventional bidirectional
Sanger sequencing was performed for this specific gene
in 11 persons (6 sporadic and 5 familial individuals) with
an isolated, bilateral form of CAA type IIA and normally
shaped pinnae. In total, four individuals and one unaf-816 The American Journal of Human Genetics 89, 813–819, Decembfected relative showed heterozygous loss-of-function
mutations, including a sporadic affected person (indi-
vidual 5), his unaffected mother, and a family with three
affected individuals consisting of a mother and her two
daughters (individuals 6–8) (Table 1).
In individual 5 (family 3), we identified a heterozygous
c.723G>A mutation, which was predicted to introduce
the premature stop codon p.(Trp241X) (Figure 2B). This
boy was the first child of healthy, nonconsanguineous
parents (Figure 1). He was born at term after an uneventful
pregnancy, had normal birth parameters, and no congen-
ital anomalies were detected. He had normal motor devel-
opment, but impaired speech and delayed language devel-
opment were noticed between the ages of 3 and 4 years.
Pure-tone audiometry at the age of five demonstrated
a 42 dB bilateral conductive hearing loss due to CAA type
IIA (Figure 3B). A BAHA Softband and subsequent percuta-
neous titanium BAHAs were applied successfully.
Physical examination at the age of 10 years showed no
facial dysmorphisms or other features associated with the
previously determined critical 18q deletion regions thater 9, 2011
Figure 3. CT Scan Images of Individuals with an
18q Deletion or TSHZ1 Mutation
An axial CT scan of individual 1 (A) shows
a narrow external auditory canal with a normal
tympanic membrane and a grommet (white
arrow) in place of the right ear. (B) shows an
axial-plane bilateral CT scan of individual 5
with bilateral CAA type IIA (stars). (C) shows
a coronal CT reconstruction of individual 7,
demonstrating a CAA type IIA (arrow) and (D)
shows a coronal CT reconstruction of individual
8, demonstrating a CAA type IIA (arrow).include TSHZ1. Segregation studies revealed that the
detected stop mutation was also present in his phenotypi-
cally normal mother. Examination of her ears demon-
strated no abnormalities to the external auditory canal or
to the tympanic membrane or her hearing.
In family 4 (Figure 1), we identified a frameshift muta-
tion due to a single base pair insertion (c.946_947delinsA),
which is predicted to cause the premature stop codon
p.Pro316ThrfsX16 (Figure 2B). As expected, this mutation
showed an autosomal-dominant segregation pattern. The
affected mother of this family (individual 6) had isolated
bilateral conductive hearing loss due to CAA type IIA, for
which she had bilateral surgical treatment at the age of 3.
Her hearing declined slowly over the following decades,
and she recently received a BAHA on the left side at
42 years of age.
Individuals 7 and 8, a monozygotic twin pair, are the
daughters of individual 6 and also both displayed CAA
type IIA (Figures 3C and 3D). They had undergone a canal-
plasty on one ear, and on the contralateral ear, they wore
a bone-anchored hearing aid. The mother and daughters
showed no notable dysmorphic facial features or any other
abnormalities associated with 18q deletion syndrome. It is
worth noting that a sequence analysis of the phenotypi-
cally normal maternal parents did not reveal the presence
of this frameshift mutation, indicating that the mutation
occurred de novo in the index person of this family.
The remaining seven individuals did not show any base
pair mutations in the coding sequence of TSHZ1.For these
individuals, whole-gene deletions were excluded with the
Cytogenetics Whole-Genome 2.7M Array (Affymetrix)
according to the manufacturer’s instructions.
To test the (clinical) specificity of TSHZ1 mutations, we
subsequently tested a cohort of 24 individuals with a
unilateral form of CAA type I, IIB, or III (Table S1, availableThe American Journal of Humaonline). In 10 of the 24 individuals, the
CAA phenotype was accompanied by mild
to severe developmental malformation of
the external ear(s), such as microtia or ano-
tia. Sanger sequencing did not reveal any
causal mutations in this cohort.
In previous studies, we proposed, in
accordance with reports of other groups, 17
that the critical region for isolated CAA waslocated on chromosome 18q22.3.14,18 This region was
reported to contain nine candidate genes, yet none of
the reports mentioned TSHZ1 as a potential candidate
for CAA.
We detected two small overlapping 18q microdeletions
in individuals with CAA as a common feature, narrowing
the critical interval for CAA to 72.9–73.4 Mb and establish-
ing TSHZ1 as a strong candidate for the CAA gene. The
subsequent detection of both a nonsense and a frameshift
mutation in TSHZ1 in two families with nonsyndromic
CAA clearly shows that hemizygosity of TSHZ1 indeed
leads to isolated CAA through haploinsufficiency. This
observation further suggests that other genes in the previ-
ously established critical region in 18q22.3 should be more
relevant to the intellectual disability, facial dysmorphisms,
and foot deformities that are commonly seen in the 18q
deletion syndrome.
The members of family 2 (individuals 2, 3, and 4) dis-
played a collection of features including characteristic
facial features, bilateral CAA, and vertical talus. The
mother and sons described here very much resembled
the phenotype of three males and three females in a family
described by Rasmussen in 1979 (MIM 133705).21 Possibly,
hemizygosity of one of the other four genes deleted in indi-
viduals 2–4, namely ZNF516, ZNF236 (MIM 604760),MBP
(MIM 159430), and GALR1 (MIM 600377), could lead to
haploinsufficiency and cause congenital foot deformities
like vertical talus. Molecular analysis of the family
members described by Rasmussen could provide more
insight into the hypothesis that Rasmussen syndrome is
caused by a microdeletion, which is identical or at least
overlapping with the deletion detected in individuals 2–4
in our study.
TSHZ1 consists of two exons, of which only exon 2 is
coding and has a genomic size of 79 kb. TSHZ1 is amembern Genetics 89, 813–819, December 9, 2011 817
of the teashirt-type zinc-finger protein family and encodes
putative zinc finger transcription factors that are broadly
expressed during mouse embryogenesis.22 In vertebrates,
three TSHZ1-related genes (TSHZ1, TSHZ2 [MIM 614118],
and TSHZ3 [MIM 614119]) have been isolated on the basis
of sequence homology.
Recently, knockout mice have been generated for
Tshz1.19 Tshz1 inactivation in mice leads to neonatal
lethality and causes multiple developmental abnormali-
ties, including a severe middle-ear phenotype that mimics
defects observed in individuals with isolated CAA. In addi-
tion, Tshz1-deficient mice show a defect of the soft palate,
a feature which was not seen in any of the individuals in
the current study. The phenotype of Tshz1-deficient mice
resembles the phenotype seen in Hoxa3 and Sall3 mouse
mutants.23,24 Interestingly, the gene families to which
these genes belong—the Hox and Spalt gene families—
genetically interact with teashirt (tsh) in Drosophila.25
Possibly, mutations in genes of these families give rise to
a similar CAA phenotype, either isolated or as part of
amore complex syndrome. Possible candidate genesmight
include other members of the teashirt zinc-finger protein
family, such as TSHZ2 and TSHZ3, and members of the
human HOX and SPALT families. A member of the HOX
family, HOXA2 (MIM 604685), has indeed been described
as playing a crucial role in auditory-systemmalformations,
more specifically in an autosomal-recessive form of
bilateral microtia, hearing impairment, and partial cleft
palate.26 Similar to what we now observe for TSHZ1, the
human phenotype caused by HOXA2 mutations is in
concordance with that of the Hoxa2 knockout mouse.27
However, DNA-sequence analysis of HOXA2 in individuals
with isolated microtia did not reveal mutations.28 In the
same fashion, not all individuals with an isolated form of
CAA type IIA selected for the present study showed muta-
tions in TSHZ1; this finding is in line with the fact that
CAA is observed as an endophenotype in multiple
syndromes, thereby suggesting that several CAA genes still
await discovery.
Most individuals with a terminal 18q deletion have been
diagnosed with CAA type I or II.29 Also, all persons in this
study had normal external-ear morphology, a finding that
is consistent with the observation that the majority of 18q
deletion individuals either have normal external ears or
show only minor abnormalities such as low-set ears or
prominent helices.
On the basis of our observation that intragenic muta-
tions in TSHZ1 could only be detected in the four individ-
uals with isolated CAA type IIA who, except for their
narrow or atretic auditory canals, have no other congenital
malformations, it might be speculated that hemizygosity
of TSHZ1 is limited to and specific to this type of CAA.
The fact that the nonsense mutation in TSHZ1 in indi-
vidual 5 was inherited from his phenotypically normal
mother can be explained by reduced penetrance. This
observation is in accordance with previous reports that
describe a CAA incidence of 26% in individuals with an818 The American Journal of Human Genetics 89, 813–819, Decemb18q deletion of any kind and an incidence of up to 78%
in individuals with a deletion of the critical CAA region
that includes TSHZ1.12,16,30 Therefore, nonpenetrance is
not unexpected in a carrier of a mutation in the CAA gene.
In conclusion, we have detected both point mutations
and copy-number variants leading to haploinsufficiency
due to hemizygosity of TSHZ1 as causes of bilateral CAA
type II (in the absence of microtia or anotia) both in iso-
lated nonsyndromic individuals and in persons with the
18q deletion syndrome. Our results provide compelling
evidence that the 18q deletion syndrome is a true contig-
uous gene syndrome, in which the CAA endophenotype
is explained by the deletion of TSHZ1. Detailed geno-
type-phenotype studies might further delineate the other
phenotypic components of this syndrome.Supplemental Data
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